1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet. 2020;395(10223):497-506.
2. Organization WH. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance, 13 March 2020. World Health Organization; 2020.
3. Desforges M, Le Coupanec A, Dubeau P, Bourgouin A, Lajoie L, Dubé M, et al. Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System? Viruses. 2020;12(1):14.
4. Li Y, Wang M, Zhou Y, Chang J, Xian Y, Mao L, et al. Acute Cerebrovascular Disease Following COVID-19: A Single Center, Retrospective, Observational Study. 2020.
5. Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain, Behavior, and Immunity. 2020.
6. Doobay MF, Talman LS, Obr TD, Tian X, Davisson RL, Lazartigues E. Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 2007;292(1):R373-R81.
7. Giacomelli A, Pezzati L, Conti F, Bernacchia D, Siano M, Oreni L, et al. Self-reported http://www. jimmunol. org/Downloaded from olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study. Clin Infect Dis. 2020.
8. Zubair AS, McAlpine LS, Gardin T, Farhadian S, Kuruvilla DE, Spudich S. Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review. JAMA neurology. 2020;77(8):1018-27.
9. Desforges M, Le Coupanec A, Brison É, Meessen-Pinard M, Talbot PJ. Neuroinvasive and neurotropic human respiratory coronaviruses: potential neurovirulent agents in humans. Infectious Diseases and Nanomedicine I. 2014:75-96.
10. Dantzer R. Neuroimmune interactions: from the brain to the immune system and vice versa. Physiological reviews. 2018;98(1):477-504.
11. Najjar S, Pahlajani S, De Sanctis V, Stern JN, Najjar A, Chong D. Neurovascular unit dysfunction and blood–brain barrier hyperpermeability contribute to schizophrenia neurobiology: a theoretical integration of clinical and experimental evidence. Frontiers in psychiatry. 2017;8:83.
12. Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, et al. Neurologic features in severe SARS-CoV-2 infection. New England Journal of Medicine. 2020;382(23):2268-70.
13. Najjar S, Najjar A, Chong DJ, Pramanik BK, Kirsch C, Kuzniecky RI, et al. Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports. Journal of neuroinflammation. 2020;17(1):1-14.
14. Slooter AJ, Otte WM, Devlin JW, Arora RC, Bleck TP, Claassen J, et al. Updated nomenclature of delirium and acute encephalopathy: statement of ten Societies. Intensive care medicine. 2020:1-3.
15. Girard TD, Thompson JL, Pandharipande PP, Brummel NE, Jackson JC, Patel MB, et al. Clinical phenotypes of delirium during critical illness and severity of subsequent long-term cognitive impairment: a prospective cohort study. The Lancet Respiratory medicine. 2018;6(3):213-22.
16. Organization WH. Clinical management of COVID-19: interim guidance, 27 May 2020. World Health Organization; 2020.
17. Ely EW, Margolin R, Francis J, May L, Truman B, Dittus R, et al. Evaluation of delirium in critically ill patients: validation of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). Critical care medicine. 2001;29(7):1370-9.
18. Toro A, Escobar L, Franco JG, Díaz-Gómez J, Muñoz J, Molina F, et al. Versión en español del método para la evaluación de la confusión en cuidados intensivos, estudio piloto de validación. Medicina intensiva. 2010;34(1):14-21.
19. Bursac Z, Gauss CH, Williams DK, Hosmer DW. Purposeful selection of variables in logistic regression. Source code for biology and medicine. 2008;3(1):1-8.
20. Kissoon NR, Mandrekar JN, Fugate JE, Lanzino G, Wijdicks EF, Rabinstein AA. Positive fluid balance is associated with poor outcomes in subarachnoid hemorrhage. Journal of Stroke and Cerebrovascular Diseases. 2015;24(10):2245-51.
21. Zweifel C, Castellani G, Czosnyka M, Carrera E, Brady KM, Kirkpatrick PJ, et al. Continuous assessment of cerebral autoregulation with near-infrared spectroscopy in adults after subarachnoid hemorrhage. Stroke. 2010;41(9):1963-8.
22. Frontera JA, Claassen J, Schmidt JM, Wartenberg KE, Temes R, Connolly ES, et al. Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale. Neurosurgery. 2006;59(1):21-7.
23. Mostafa S, Bhandari S, Ritchie G, Gratton N, Wenstone R. Constipation and its implications in the critically ill patient. British journal of anaesthesia. 2003;91(6):815-9.
24. Khan SH, Lindroth H, Perkins AJ, Jamil Y, Wang S, Roberts S, et al. Delirium Incidence, Duration, and Severity in Critically Ill Patients With Coronavirus Disease 2019. Critical care explorations. 2020;2(12).
25. Emmerton D, Abdelhafiz A. Delirium in older people with COVID-19: Clinical scenario and literature review. SN Comprehensive Clinical Medicine. 2020:1-8.
26. O'keeffe S, Lavan J. Predicting delirium in elderly patients: development and validation of a risk-stratification model. Age and Ageing. 1996;25(4):317-21.
27. Garcez FB, Aliberti MJ, Poco PC, Hiratsuka M, Takahashi SdF, Coelho VA, et al. Delirium and adverse outcomes in hospitalized patients with COVID‐19. Journal of the American Geriatrics Society. 2020;68(11):2440-6.
28. Ticinesi A, Cerundolo N, Parise A, Nouvenne A, Prati B, Guerra A, et al. Delirium in COVID-19: epidemiology and clinical correlations in a large group of patients admitted to an academic hospital. Aging clinical and experimental research. 2020;32(10):2159-66.
29. Dubois M-J, Bergeron N, Dumont M, Dial S, Skrobik Y. Delirium in an intensive care unit: a study of risk factors. Intensive care medicine. 2001;27(8):1297-304.
30. Ouimet S, Kavanagh BP, Gottfried SB, Skrobik Y. Incidence, risk factors and consequences of ICU delirium. Intensive care medicine. 2007;33(1):66-73.
31. Rebora P, Rozzini R, Bianchetti A, Blangiardo P, Marchegiani A, Piazzoli A, et al. Delirium in patients with SARS‐CoV‐2 infection: a multicenter study. Journal of the American Geriatrics Society. 2021;69(2):293-9.
32. Bushnell CD, Lee J, Duncan PW, Newby LK, Goldstein LB. Impact of comorbidities on ischemic stroke outcomes in women. Stroke. 2008;39(7):2138-40.
33. Hartley P, Adamson J, Cunningham C, Embleton G, Romero‐Ortuno R. Clinical frailty and functional trajectories in hospitalized older adults: a retrospective observational study. Geriatrics & gerontology international. 2017;17(7):1063-8.
34. Amanat M, Rezaei N, Roozbeh M, Shojaei M, Tafakhori A, Zoghi A, et al. Neurological manifestations as the predictors of severity and mortality in hospitalized individuals with COVID-19: a multicenter prospective clinical study. BMC neurology. 2021;21(1):1-12.
35. Maldonado JR. Delirium pathophysiology: An updated hypothesis of the etiology of acute brain failure. International journal of geriatric psychiatry. 2018;33(11):1428-57.
36. Rincon HG, Granados M, Unutzer J, Gomez M, Duran R, Badiel M, et al. Prevalence, detection and treatment of anxiety, depression, and delirium in the adult critical care unit. Psychosomatics. 2001;42(5):391-6.
37. MacLullich AM, Ferguson KJ, Miller T, de Rooij SE, Cunningham C. Unravelling the pathophysiology of delirium: a focus on the role of aberrant stress responses. Journal of psychosomatic research. 2008;65(3):229-38.
38. Nauka PC, Baron SW, Assa A, Mohrmann L, Jindal S, Oran E, et al. Utility of D-dimer in predicting venous thromboembolism in non-mechanically ventilated COVID-19 survivors. Thrombosis research. 2021;199:82-4.
39. Ordieres-Ortega L, Demelo-Rodríguez P, Galeano-Valle F, Kremers B, Ten Cate-Hoek A, Ten Cate H. Predictive value of D-dimer testing for the diagnosis of venous thrombosis in unusual locations: a systematic review. Thrombosis research. 2020;189:5-12.
40. Nickel CH, Kellett J, Cooksley T, Lyngholm LE, Chang S, Imfeld S, et al. The diagnoses and outcomes of emergency patients with an elevated D-dimer over the next 90 days. The American Journal of Medicine. 2021;134(2):260-6. e2.
41. Jaywant A, Vanderlind WM, Alexopoulos GS, Fridman CB, Perlis RH, Gunning FM. Frequency and profile of objective cognitive deficits in hospitalized patients recovering from COVID-19. Neuropsychopharmacology. 2021:1-6.